18 | Prednisolone (Predate)FDA LinkGeneric
01/2020
-
06/2002 |
18 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020
-
06/2002 |
17 | Rituximab (Mabthera)FDA Link
02/2022
-
10/2006 |
16 | Vincristine (Oncovin)FDA LinkGeneric
10/2018
-
06/2002 |
14 | Proteins (Proteins, Gene)FDA Link
10/2020
-
05/2004 |
13 | Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018
-
02/2004 |
9 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
04/2020
-
04/2011 |
8 | pirarubicinIBA
10/2018
-
02/2004 |
8 | KynurenineIBA
12/2017
-
04/2010 |
8 | 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
10/2013
-
05/2004 |
6 | Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2016
-
02/2010 |
6 | Messenger RNA (mRNA)IBA
01/2016
-
01/2011 |
6 | AdipokinesIBA
01/2015
-
07/2010 |
5 | AzoxymethaneIBA
07/2014
-
05/2008 |
5 | Retinoid X Receptors (Retinoid X Receptor)IBA
10/2012
-
03/2007 |
5 | epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2012
-
05/2008 |
5 | RetinoidsIBA
11/2009
-
05/2004 |
4 | Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2022
-
12/2005 |
4 | Tryptophan (L-Tryptophan)FDA Link
04/2020
-
09/2012 |
4 | Etoposide (VP 16)FDA LinkGeneric
09/2017
-
06/2002 |
4 | TeaIBA
01/2013
-
05/2008 |
4 | Branched-Chain Amino AcidsIBA
12/2012
-
05/2009 |
4 | Interleukin-2 Receptors (IL 2 Receptor)IBA
05/2012
-
11/2002 |
4 | beta CateninIBA
07/2010
-
10/2007 |
4 | Insulin-Like PeptidesIBA
05/2010
-
09/2008 |
3 | Cytarabine (Cytosar-U)FDA LinkGeneric
02/2022
-
08/2007 |
3 | MethylprednisoloneFDA LinkGeneric
02/2022
-
08/2003 |
3 | polaprezinc (Z 103)IBA
01/2021
-
12/2014 |
3 | Monoclonal AntibodiesIBA
04/2020
-
06/2005 |
3 | Interleukin-6 (Interleukin 6)IBA
11/2018
-
01/2011 |
3 | Carboplatin (JM8)FDA LinkGeneric
09/2017
-
06/2002 |
3 | Red Fluorescent ProteinIBA
04/2016
-
09/2015 |
3 | EnzymesIBA
01/2016
-
09/2012 |
3 | Antineoplastic Agents (Antineoplastics)IBA
01/2015
-
05/2004 |
3 | LigandsIBA
10/2012
-
05/2004 |
3 | Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2012
-
05/2004 |
3 | Pharmaceutical PreparationsIBA
06/2012
-
01/2009 |
3 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2011
-
07/2002 |
3 | Drinking WaterIBA
06/2011
-
05/2008 |
3 | tyrosine receptor (receptor, tyrosine)IBA
05/2010
-
10/2009 |
3 | Phosphotransferases (Kinase)IBA
05/2010
-
10/2009 |
3 | Retinoid X Receptor alphaIBA
11/2009
-
10/2007 |
3 | Vitamin A (Retinol)FDA LinkGeneric
01/2009
-
05/2004 |
3 | AlitretinoinFDA Link
01/2009
-
11/2007 |
2 | Dasatinib (BMS 354825)FDA Link
02/2022
-
10/2018 |
2 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
-
05/2010 |
2 | ProgranulinsIBA
01/2021
-
10/2017 |
2 | IfosfamideFDA LinkGeneric
09/2017
-
06/2002 |